IART logo

Integra LifeSciences Holdings (IART) Long Term Liabilities

Annual Total Long Term Liabilities

$1.89 B
+$122.67 M+6.95%

31 December 2023

IART Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Long Term Liabilities

$1.63 B
-$580.33 M-26.24%

30 September 2024

IART Quarterly Long Term Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IART Long Term Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year--13.5%
3 y3 years+7.4%-7.2%
5 y5 years+21.3%+4.9%

IART Long Term Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 yearsat high+11.1%-26.2%at low
5 y5 yearsat high+28.4%-26.2%+4.9%
alltimeall time-0.7%>+9999.0%-26.2%>+9999.0%

Integra LifeSciences Holdings Long Term Liabilities History

DateAnnualQuarterly
Sept 2024
-
$1.63 B(-26.2%)
June 2024
-
$2.21 B(+1.6%)
Mar 2024
-
$2.18 B(+15.4%)
Dec 2023
$1.89 B(+7.0%)
$1.89 B(+4.6%)
Sept 2023
-
$1.80 B(+5.1%)
June 2023
-
$1.72 B(-3.8%)
Mar 2023
-
$1.79 B(+1.2%)
Dec 2022
$1.76 B(+0.4%)
$1.76 B(-0.8%)
Sept 2022
-
$1.78 B(-1.0%)
June 2022
-
$1.80 B(+3.2%)
Mar 2022
-
$1.74 B(-0.9%)
Dec 2021
$1.76 B(+3.4%)
$1.76 B(-2.9%)
Sept 2021
-
$1.81 B(-0.5%)
June 2021
-
$1.82 B(+1.1%)
Mar 2021
-
$1.80 B(+5.9%)
Dec 2020
$1.70 B(+9.3%)
$1.70 B(-5.6%)
Sept 2020
-
$1.80 B(-1.6%)
June 2020
-
$1.83 B(-1.6%)
Mar 2020
-
$1.86 B(+19.6%)
Dec 2019
$1.56 B(+5.8%)
$1.56 B(-6.3%)
Sept 2019
-
$1.66 B(+6.7%)
June 2019
-
$1.55 B(+2.2%)
Mar 2019
-
$1.52 B(+3.5%)
Dec 2018
$1.47 B(-22.7%)
$1.47 B(-5.5%)
Sept 2018
-
$1.56 B(-3.4%)
June 2018
-
$1.61 B(-15.8%)
Mar 2018
-
$1.91 B(+0.7%)
Dec 2017
$1.90 B(+124.9%)
$1.90 B(+46.7%)
Sept 2017
-
$1.29 B(+25.9%)
June 2017
-
$1.03 B(+2.0%)
Mar 2017
-
$1.01 B(+19.4%)
Dec 2016
$844.69 M(-4.4%)
$844.69 M(+0.2%)
Sept 2016
-
$842.60 M(-3.1%)
June 2016
-
$869.55 M(-3.1%)
Mar 2016
-
$897.25 M(+1.5%)
Dec 2015
$883.65 M(+16.7%)
$883.65 M(-7.7%)
Sept 2015
-
$957.57 M(+24.3%)
June 2015
-
$770.42 M(+4.7%)
Mar 2015
-
$735.90 M(-2.8%)
Dec 2014
$757.07 M(+86.2%)
$757.07 M(+3.8%)
Sept 2014
-
$729.63 M(-2.3%)
June 2014
-
$746.89 M(-1.7%)
Mar 2014
-
$759.89 M(+86.9%)
Dec 2013
$406.67 M(-24.5%)
$406.67 M(-27.7%)
Sept 2013
-
$562.32 M(+0.1%)
June 2013
-
$561.57 M(+3.8%)
Mar 2013
-
$540.82 M(+0.4%)
Dec 2012
$538.89 M(-1.9%)
$538.89 M(-1.3%)
Sept 2012
-
$546.23 M(+0.7%)
June 2012
-
$542.36 M(-0.5%)
Mar 2012
-
$545.33 M(-0.8%)
Dec 2011
$549.60 M(+73.2%)
$549.60 M(-3.4%)
Sept 2011
-
$568.71 M(+10.0%)
June 2011
-
$517.03 M(+63.6%)
Mar 2011
-
$316.13 M(-0.4%)
Dec 2010
$317.31 M
$317.31 M(-17.7%)
Sept 2010
-
$385.77 M(-2.5%)
June 2010
-
$395.78 M(+23.3%)
DateAnnualQuarterly
Mar 2010
-
$320.90 M(-5.2%)
Dec 2009
$338.49 M(-29.3%)
$338.49 M(+3.4%)
Sept 2009
-
$327.49 M(+0.2%)
June 2009
-
$326.76 M(-27.5%)
Mar 2009
-
$450.48 M(-5.9%)
Dec 2008
$478.95 M(+30.9%)
$478.95 M(+33.6%)
Sept 2008
-
$358.55 M(+2.7%)
June 2008
-
$349.13 M(-4.8%)
Mar 2008
-
$366.67 M(+0.2%)
Dec 2007
$365.91 M(+742.4%)
$365.91 M(-1.5%)
Sept 2007
-
$371.50 M(-0.1%)
June 2007
-
$371.95 M(+749.5%)
Mar 2007
-
$43.78 M(+0.8%)
Dec 2006
$43.44 M(-65.9%)
$43.44 M(-0.2%)
Sept 2006
-
$43.52 M(-69.0%)
June 2006
-
$140.55 M(+9.1%)
Mar 2006
-
$128.81 M(+1.2%)
Dec 2005
$127.33 M(+2.1%)
$127.33 M(+2.1%)
Sept 2005
-
$124.74 M(+0.0%)
June 2005
-
$124.73 M(-0.3%)
Mar 2005
-
$125.08 M(+0.3%)
Dec 2004
$124.66 M(+1.0%)
$124.66 M(+0.7%)
Sept 2004
-
$123.79 M(-0.1%)
June 2004
-
$123.94 M(+0.4%)
Mar 2004
-
$123.43 M(+0.0%)
Dec 2003
$123.38 M(+2295.7%)
$123.38 M(+0.3%)
Sept 2003
-
$123.03 M(-1.5%)
June 2003
-
$124.91 M(+13.7%)
Mar 2003
-
$109.89 M(+2033.8%)
Dec 2002
$5.15 M(+17.4%)
$5.15 M(+30.4%)
Sept 2002
-
$3.95 M(-4.1%)
June 2002
-
$4.12 M(-2.4%)
Mar 2002
-
$4.22 M(-3.8%)
Dec 2001
$4.38 M(-62.5%)
$4.38 M(-36.9%)
Sept 2001
-
$6.95 M(-27.0%)
June 2001
-
$9.53 M(-2.1%)
Mar 2001
-
$9.73 M(-16.8%)
Dec 2000
$11.69 M(-13.2%)
$11.69 M(-15.2%)
Sept 2000
-
$13.79 M(-5.1%)
June 2000
-
$14.53 M(+5.1%)
Mar 2000
-
$13.83 M(+2.7%)
Dec 1999
$13.47 M(+4390.7%)
$13.47 M(-17.9%)
Sept 1999
-
$16.40 M(-1.2%)
June 1999
-
$16.60 M(+25.8%)
Mar 1999
-
$13.20 M(+4300.0%)
Dec 1998
$300.00 K(+50.0%)
$300.00 K(+50.0%)
Sept 1998
-
$200.00 K(-33.3%)
June 1998
-
$300.00 K(0.0%)
Mar 1998
-
$300.00 K(+50.0%)
Dec 1997
$200.00 K(+100.0%)
$200.00 K(+100.0%)
Sept 1997
-
$100.00 K(0.0%)
June 1997
-
$100.00 K(-50.0%)
Mar 1997
-
$200.00 K(+100.0%)
Dec 1996
$100.00 K(-50.0%)
$100.00 K(0.0%)
Sept 1996
-
$100.00 K(-50.0%)
June 1996
-
$200.00 K(+100.0%)
Mar 1996
-
$100.00 K(-50.0%)
Dec 1995
$200.00 K
$200.00 K(0.0%)
Sept 1995
-
$200.00 K

FAQ

  • What is Integra LifeSciences Holdings annual total long term liabilities?
  • What is the all time high annual total long term liabilities for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly total long term liabilities?
  • What is the all time high quarterly long term liabilities for Integra LifeSciences Holdings?
  • What is Integra LifeSciences Holdings quarterly long term liabilities year-on-year change?

What is Integra LifeSciences Holdings annual total long term liabilities?

The current annual total long term liabilities of IART is $1.89 B

What is the all time high annual total long term liabilities for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high annual total long term liabilities is $1.90 B

What is Integra LifeSciences Holdings quarterly total long term liabilities?

The current quarterly long term liabilities of IART is $1.63 B

What is the all time high quarterly long term liabilities for Integra LifeSciences Holdings?

Integra LifeSciences Holdings all-time high quarterly total long term liabilities is $2.21 B

What is Integra LifeSciences Holdings quarterly long term liabilities year-on-year change?

Over the past year, IART quarterly total long term liabilities has changed by -$255.47 M (-13.54%)